Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Fate Therapeutics, Inc. (FATE)

« Back to company index

FATE Chatter Timeline

Stock Ticker for FATE

Most Active Tweeters for FATE

No tweets found

Recent Tweets for FATE

MareaInformativ @MareaInformativ
Fate Therapeutics $FATE Earning Somewhat Positive Press Coverage, Study Shows https://t.co/7b5oN743lB
August 21st 2018, 9:08pm
bibeypost_stock @bibeypost_stock
What's Next for Fate Therapeutics, Inc. $FATE After Forming Bullish Double Top? - https://t.co/Xp4i0uAtyE
August 21st 2018, 8:08pm
mmahotstuff1 @mmahotstuff1
Could Fate Therapeutics, Inc. $FATE Increase Even More? The Stock Formed Double Top Chart Pattern - https://t.co/iZjFCBquxs
August 21st 2018, 8:08pm
reurope_stock @reurope_stock
Could Fate Therapeutics, Inc. $FATE Go Up? The Stock Formed Double Top https://t.co/UXMb0uu6M2
August 21st 2018, 8:08pm
The_CasualSmart @The_CasualSmart
Fate Therapeutics, Inc. $FATE on Focus After Forming Bullish Double Top Pattern https://t.co/xBHMfuIkBT
August 21st 2018, 8:08pm
west_moreland @west_moreland
Bullish Chart Formation for Fate Therapeutics, Inc. $FATE After Forming Bullish Double Top Chart Pattern https://t.co/lENsD2qxRN
August 21st 2018, 8:08pm
The_CasualSmart @The_CasualSmart
After Forming Bullish Double Top, Is Fate Therapeutics, Inc. $FATE's Near-Term Analysis Positive? https://t.co/GZGt8uRB1N
August 21st 2018, 8:08pm
Fanob_stock @Fanob_stock
Fate Therapeutics, Inc. $FATE Could Help Your Portfolio. The Stock Formed Bullish Double Top Pattern https://t.co/pfINchbaIk
August 21st 2018, 8:08pm
TheMarketsDaily @TheMarketsDaily
-$0.27 EPS Expected for Fate Therapeutics Inc $FATE This Quarter https://t.co/4hnNtDx5c0
August 21st 2018, 11:08am
MareaInformativ @MareaInformativ
Fate Therapeutics $FATE Upgraded by BidaskClub to Buy https://t.co/9LFZe82iHv
August 21st 2018, 10:08am
registrarjourn @registrarjourn
Fate Therapeutics $FATE Cut to Hold at BidaskClub https://t.co/gNnBJRWtmQ
August 21st 2018, 4:08am
EnterpriseLeade @EnterpriseLeade
Fate Therapeutics $FATE Cut to Hold at BidaskClub https://t.co/LrhBvRYcw1
August 21st 2018, 4:08am
ThisLincolnian @ThisLincolnian
Analysts Set Fate Therapeutics Inc $FATE Target Price at $16.71 https://t.co/6DOVYb0Ta0
August 20th 2018, 11:08am
usindexlive @usindexlive
Copeland Capital Management Has Trimmed Its Boeing Co $BA Holding; Fate Therapeutics, Inc. $FATE Covered By 5 Bulls https://t.co/1IUsUKwOBC
August 19th 2018, 8:08am
MareaInformativ @MareaInformativ
Fate Therapeutics $FATE Earning Somewhat Positive Media Coverage, Study Finds https://t.co/ji7Anc5HXE
August 18th 2018, 11:08pm
registrarjourn @registrarjourn
Fate Therapeutics $FATE Getting Somewhat Favorable Media Coverage, Study Shows https://t.co/VIGoVtXzzx
August 18th 2018, 10:08pm
EnterpriseLeade @EnterpriseLeade
Fate Therapeutics $FATE Getting Somewhat Favorable Media Coverage, Study Shows https://t.co/5mQRQ36dDm
August 18th 2018, 10:08pm
bibeypost_stock @bibeypost_stock
Fate Therapeutics Inc $FATE Quarterly Sentiment Change Report - https://t.co/27OKxlYkb3
August 18th 2018, 10:08am
mmahotstuff1 @mmahotstuff1
Institutional Investor Sentiment About Fate Therapeutics Inc $FATE Improved - https://t.co/fErRUBw5XI
August 18th 2018, 10:08am
whatsonthorold2 @whatsonthorold2
Institutional Investor Sentiment About Fate Therapeutics Inc $FATE Up - https://t.co/ACCDMz7QLL
August 18th 2018, 10:08am
west_moreland @west_moreland
Institutional Investors Are Betting On Fate Therapeutics Inc $FATE https://t.co/WuEzvOn2M6
August 18th 2018, 10:08am
Fanob_stock @Fanob_stock
Fate Therapeutics Inc $FATE Institutional Investors Sentiment Improved in Q1 2018 https://t.co/gcbvQPz89X
August 18th 2018, 10:08am
MareaInformativ @MareaInformativ
Fate Therapeutics $FATE Receives “Hold” Rating from HC Wainwright https://t.co/5ve5Khyufa
August 18th 2018, 7:08am
MareaInformativ @MareaInformativ
Fate Therapeutics $FATE Raised to Hold at Zacks Investment Research https://t.co/KEKUQlZT7z
August 17th 2018, 12:08pm
dakotafinancial @dakotafinancial
Fate Therapeutics Inc $FATE Receives Consensus Recommendation of “Buy” from Analysts https://t.co/AV5Vo8jtZ3
August 17th 2018, 3:08am
AmericanBanking @AmericanBanking
Fate Therapeutics Inc $FATE Given Consensus Recommendation of “Buy” by Brokerages https://t.co/gBioN1xA6d #stocks
August 17th 2018, 3:08am
MareaInformativ @MareaInformativ
Financial Survey: Fate Therapeutics $FATE and Vical $VICL https://t.co/3Saa1rjLuk
August 15th 2018, 10:08pm
registrarjourn @registrarjourn
Fate Therapeutics Inc $FATE Expected to Post Quarterly Sales of $1.27 Million https://t.co/TK2N8GyFJF
August 15th 2018, 5:08am
ChartMill @ChartMill
Besides having an excellent technical rating, $FATE also presents a decent setup pattern. https://t.co/tH00tGbXFV https://t.co/GBVBmIHXEr
August 14th 2018, 8:08pm
MareaInformativ @MareaInformativ
Fate Therapeutics $FATE Announces Earnings Results, Misses Estimates By $0.05 EPS https://t.co/i4Un5C9XZB
August 14th 2018, 4:08pm
registrarjourn @registrarjourn
Fate Therapeutics $FATE Earns Outperform Rating from Wedbush https://t.co/TL3VV95pKo
August 14th 2018, 10:08am
MareaInformativ @MareaInformativ
Fate Therapeutics $FATE Raised to “Buy” at BidaskClub https://t.co/9LFZe82iHv
August 14th 2018, 7:08am
bbnsnews @bbnsnews
Fate Therapeutics $FATE Raised to “Buy” at BidaskClub https://t.co/bDGa39MWrB
August 14th 2018, 6:08am
TickerReport @TickerReport
Fate Therapeutics $FATE Raised to “Buy” at BidaskClub https://t.co/djdkaORpAP
August 14th 2018, 3:08am
MareaInformativ @MareaInformativ
Zacks Investment Research Lowers Fate Therapeutics $FATE to Sell https://t.co/yr6xZ4g42v
August 14th 2018, 1:08am
VistaPResearch @VistaPResearch
RT @VistaPResearch: Fate Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference August 14 $FATE $IBB #biotech #investing…
August 13th 2018, 3:08pm
VistaPResearch @VistaPResearch
Fate Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference August 14 $FATE $IBB #biotech… https://t.co/NaPawWsPYP
August 13th 2018, 2:08pm
WatchlistN @WatchlistN
Fate Therapeutics $FATE Rating Increased to Buy at BidaskClub https://t.co/ktPyJwDitA
August 13th 2018, 12:08pm
MareaInformativ @MareaInformativ
Fate Therapeutics Inc $FATE Expected to Post Quarterly Sales of $1.27 Million https://t.co/UM6AF0qwMj
August 13th 2018, 11:08am
EnterpriseLeade @EnterpriseLeade
Fate Therapeutics $FATE Lowered to “Hold” at BidaskClub https://t.co/LrhBvRYcw1
August 13th 2018, 6:08am
ChartMill @ChartMill
Looking at the yearly performance, $FATE did better than 98% of all other stocks. https://t.co/KA8AqYLfaC https://t.co/UE8X7tSfhK
August 12th 2018, 6:08pm
MareaInformativ @MareaInformativ
Brokerages Set Fate Therapeutics Inc $FATE Price Target at $16.17 https://t.co/WSeOR4J9bB
August 12th 2018, 2:08pm
ThisLincolnian @ThisLincolnian
BidaskClub Upgrades Fate Therapeutics $FATE to “Buy” https://t.co/4vhV7WpLv9
August 12th 2018, 4:08am
ConsumerFeed @ConsumerFeed
Q3 2018 EPS Estimates for Fate Therapeutics Inc Reduced by Wedbush $FATE https://t.co/2mokCrJO1l
August 12th 2018, 1:08am
ConsumerFeed @ConsumerFeed
Fate Therapeutics $FATE Upgraded to Buy at BidaskClub https://t.co/nOWIvbfQLZ
August 11th 2018, 5:08pm
TheMarketsDaily @TheMarketsDaily
Wedbush Reiterates Outperform Rating for Fate Therapeutics $FATE https://t.co/KRqqZFAQwN
August 11th 2018, 12:08pm
bbnsnews @bbnsnews
Q3 2018 Earnings Estimate for Fate Therapeutics Inc Issued By Wedbush $FATE https://t.co/aMEwvfacay
August 11th 2018, 6:08am
EnterpriseLeade @EnterpriseLeade
Somewhat Positive Press Coverage Somewhat Unlikely to Impact Fate Therapeutics $FATE Share Price https://t.co/5mQRQ36dDm
August 11th 2018, 4:08am
ThisLincolnian @ThisLincolnian
HC Wainwright Reiterates “Hold” Rating for Fate Therapeutics $FATE https://t.co/zLmldkIHuX
August 11th 2018, 4:08am
TheMarketsDaily @TheMarketsDaily
Fate Therapeutics $FATE Earns Hold Rating from HC Wainwright https://t.co/WcvPUU08OD
August 10th 2018, 5:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.